Max Nisen, Columnist

Add a Dose of Harvard to the Bezos-Buffett-Dimon Health Mix

Atul Gawande is an intriguing CEO choice for an unusual venture.

June 20, 2018 at 4:25 PM UTC

Max Nisen is a healthcare analyst at Bloomberg Intelligence. He previously wrote for Bloomberg Opinion, Quartz and Business Insider.

Big thinker.
Photographer: Lisa Lake/Getty Images North America

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Everything about Amazon.com Inc., Berkshire Hathaway Inc., and J.P. Morgan Chase & Co.’s enigmatic effort to reduce health-care costs has been unusual.

On Wednesday, the triumverate stuck to their strange guns by picking renowned surgeon, writer and Harvard public-health researcher Atul Gawande to run their new company.